Abstract:Although Poly C Binding Protein 1 (PCBP1) affects cellular ferroptosis and mitochondrial dysfunction, the mechanisms by which PCBP1 regulates bladder cancer (BC) cell functions are unknown. In this study, two BC cell lines (T24 and UMUC3) were treated with different doses of ferroptosis inducer erastin to analyze the effect of PCBP1. Online databases (RPISeq and CatRAPID) were used to predict the possible direct interaction between PCBP1 protein and serine β‐lactamase‐like protein (LACTB) mRNA, which was further validated via RNA pull‐down, RNA immunoprecipitation, and luciferase reporter assays. Mitochondria injury and ferroptosis were evaluated using CCK‐8 assay, TUNEL staining, flow cytometry, corresponding kits, and JC‐1 staining. In vivo experiments were conducted using tumor xenograft models. Quantitative reverse‐transcription polymerase chain reaction was used to detect transcript expression levels, while protein levels were analyzed using western blot and immunohistochemistry. PCBP1 expression was significantly upregulated in BC tissues and cell lines. Also, PCBP1 knockdown increased erastin‐mediated ferroptosis in T24 and UMUC3 cells, while PCBP1 overexpression decreased erastin‐mediated ferroptosis in T24 and UMUC3 cells. Mechanistic results showed that LACTB mRNA is a novel PCBP1‐binding transcript. LACTB upregulation promoted erastin‐induced ferroptosis and mitochondrial dysfunction. Furthermore, LACTB overexpression reversed PCBP1‐mediated ferroptosis protection, including decreased ROS and enhanced mitochondrial function, which were further alleviated after phosphatidylserine decarboxylase (PISD) overexpression. Moreover, PCBP1 silencing significantly enhanced tumor inhibition effect of sulfasalazine in xenograft mice transplanted with T24 and UMUC3 cells, leading to LACTB upregulation and PISD downregulation. In conclusion, PCBP1 protects BC cells against mitochondria injury and ferroptosis via LACTB/PISD axis.

PCBP2 Posttranscriptional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E

High Expression of UNC5B Enhances Tumor Proliferation, Increases Metastasis, and Worsens Prognosis in Breast Cancer.

Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer

CtBP2 is Associated with Angiogenesis and Regulates the Apoptosis of Prostate Cancer Cells.

LncRNA PCAT6 mediates UBFD1 expression via sponging miR-545-3p in breast cancer cells

IGF2BP2-modified UBE2D1 Interacts with Smad2/3 to Promote the Progression of Breast Cancer.

C-terminal Binding Protein-2 Promotes Cell Proliferation and Migration in Breast Cancer Via Suppression of P16ink4a

Comprehensive Analysis of PPPCs Family Reveals the Clinical Significance of PPP1CA and PPP4C in Breast Cancer.

Up-regulation and Worse Prognostic Marker of Cytoplasmic TARBP2 Expression in Obstinate Breast Cancer

RNA-binding Protein PCBP2 Modulates Glioma Growth by Regulating FHL3.

NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1

Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway

Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer

Correction: M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2

The far-upstream element-binding protein 2 is correlated with proliferation and doxorubicin resistance in human breast cancer cell lines

Stabilization of IGF2BP1 by USP10 Promotes Breast Cancer Metastasis Via CPT1A in an M6a-Dependent Manner

Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis

PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation

PCDHA1 High Expression is Associated With Poor Prognosis and Correlated With Immune Cell Infiltration in Breast Cancer

PFDN5 plays a dual role in breast cancer and regulates tumor immune microenvironment: Insights from integrated bioinformatics analysis and experimental validation